Mepirapim, a novel synthetic cannabinoid, induces Parkinson’s disease-related behaviors by causing maladaptation of the dopamine system in the brain
Article in Archives of Toxicology (November 2022)
The most recent citing publications are shown below. View all 58 publications that cite this research output on Dimensions.
Article in Archives of Toxicology (November 2022)
Article in Pharmaceuticals (June 2022)
Article in ACS Chemical Neuroscience (April 2022)